Royston, United Kingdom

Martin E Fox

This inventor holds 1 USPTO granted patent. Top assignee: Dr. Reddy's Laboratories, Incorporated. Active years: 2011.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin E Fox: Innovator in Asymmetric Reactions

Introduction

Martin E Fox is a notable inventor based in Royston, GB. He has made significant contributions to the field of chemistry, particularly in the development of catalysts for asymmetric reactions. His work has implications for various applications in pharmaceuticals and materials science.

Latest Patents

One of Martin E Fox's key patents is titled "Bisphospholanes for use as catalysts in asymmetric reactions." This invention concerns an enantiomerically enriched compound of a specific formula, wherein each of the aromatic groups can consist of up to 20 carbon atoms. The bridging group in his invention is defined by a particular formula, which includes points of attachment to phosphorus atoms. This innovative approach enhances the efficiency of asymmetric reactions, making it a valuable contribution to the field.

Career Highlights

Martin E Fox is currently associated with Dr. Reddy's Laboratories, Incorporated, where he continues to advance his research and development efforts. His expertise in catalysis and asymmetric synthesis has positioned him as a key player in his field.

Collaborations

Some of his notable coworkers include Philip Mark Jackson and Ian Campbell Lennon. Their collaborative efforts contribute to the innovative environment at Dr. Reddy's Laboratories.

Conclusion

Martin E Fox's work exemplifies the importance of innovation in chemistry, particularly in the development of catalysts for asymmetric reactions. His contributions are paving the way for advancements in various scientific applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…